BIOSECURE Act included in Senate version of the 2026 NDAA

On October 9, the U.S. Senate adopted amendment 3841, adding Section 881, Prohibition on Contracting with Certain Biotechnology Providers, a version of the BIOSECURE Act, to its version of the FY 2026 National Defense Authorization Act (NDAA). With prior opposition to BIOSECURE apparently having been quelled, there appears to be a good chance that BIOSECURE will become law before the close of 2025, but enactment is still far from certain….
By: Hogan Lovells